Smoking after heart transplantation: An underestimated hazard?
OBJECTIVE: Risk factors for the development of vasculopathy and malignancies as the most important causes of morbidity and mortality after heart transplantation are not well defined. METHODS: Univariate and multivariate Cox regression analysis of the data derived from our 84 survivors of more than 3...
Gespeichert in:
Veröffentlicht in: | European journal of cardio-thoracic surgery 1997-07, Vol.12 (1), p.70-74 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 74 |
---|---|
container_issue | 1 |
container_start_page | 70 |
container_title | European journal of cardio-thoracic surgery |
container_volume | 12 |
creator | NÄGELE, H KALMAR, P RÖDIGER, W STUBBE, H. M |
description | OBJECTIVE: Risk factors for the development of vasculopathy and malignancies as the most important causes of morbidity and mortality after heart transplantation are not well defined. METHODS: Univariate and multivariate Cox regression analysis of the data derived from our 84 survivors of more than 3 months after orthotopic heart transplantation between 1984 and 1996. Measurement of carbonmonoxide-hemoglobin blood levels with an ABL 520 analyzer. RESULTS: Recipient or donor age, the mode of immunosuppression, total-, LDL- and HDL- cholesterol, the HDL/LDL-ratio,triglycerides, hypertension, diabetes mellitus, CMV status and rejection episodes had no independent influence on total mortality or the occurrence of graft vasculopathy or cancer. By means of an intensive questionnaire (incase of deceased patients, by their relatives) and measurement of CO-Hb blood levels we detected a high rate of patients who smoked after transplantation (22/84 = 26%). Four patients confessed smoking after undergoing the blood test. Non-smokers were defined as denying it in the questionnaire and having CO-Mb levels < 2.5% in repeated measurements.All but one were smokers before heart transplantation. Mean consumption was11 cigarettes per day. Five and 10 years survival was significantly reducedin smokers vs. non-smokers (37 vs. 80% and 10 vs. 74%, respectively, P |
doi_str_mv | 10.1016/S1010-7940(97)00156-5 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79210960</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1016/S1010-7940(97)00156-5</oup_id><sourcerecordid>79210960</sourcerecordid><originalsourceid>FETCH-LOGICAL-c493t-dbc634d725dce381e96190680ba56a30e9cfcdd22e3a4bb45c5d1a7c757556193</originalsourceid><addsrcrecordid>eNptkF1PHCEUhompUav9CSZzYRp7gR5ggKEXGrutH9WkF2o03hAGGB13d2YLTFL99WXddZMmvQGS87y8Jw9CuwQOCBBxeJ1PwFKVsK_kFwDCBeZraItUkmHJyvsP-f2ObKKPMT4DgGBUbqANRQWFim2ho-tpP267x8I0yYfiyZuQihRMF2cT0yWT2r77Wpx0xdA5H3xM7dQk74on82qCO95B642ZRP9peW-j29MfN6NzfPXr7GJ0coVtqVjCrraClU5S7qxnFfFKEAWigtpwYRh4ZRvrHKWembKuS265I0ZaySXnGWXb6PPi31nofw95DT1to_WTvKPvh6ilogSUgAzyBWhDH2PwjZ6FvHJ40QT03Jt-86bnUrSS-s2b5jm3uywY6ql3q9RSVJ7vLecmWjNpsiHbxhVGJafZbsZggfXD7P_N-J9mPG_Gi0gbk_-zCpkw1kIyyfX5_YMeiW93lxX9qb-zv7DckeM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79210960</pqid></control><display><type>article</type><title>Smoking after heart transplantation: An underestimated hazard?</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>NÄGELE, H ; KALMAR, P ; RÖDIGER, W ; STUBBE, H. M</creator><creatorcontrib>NÄGELE, H ; KALMAR, P ; RÖDIGER, W ; STUBBE, H. M</creatorcontrib><description>OBJECTIVE: Risk factors for the development of vasculopathy and malignancies as the most important causes of morbidity and mortality after heart transplantation are not well defined. METHODS: Univariate and multivariate Cox regression analysis of the data derived from our 84 survivors of more than 3 months after orthotopic heart transplantation between 1984 and 1996. Measurement of carbonmonoxide-hemoglobin blood levels with an ABL 520 analyzer. RESULTS: Recipient or donor age, the mode of immunosuppression, total-, LDL- and HDL- cholesterol, the HDL/LDL-ratio,triglycerides, hypertension, diabetes mellitus, CMV status and rejection episodes had no independent influence on total mortality or the occurrence of graft vasculopathy or cancer. By means of an intensive questionnaire (incase of deceased patients, by their relatives) and measurement of CO-Hb blood levels we detected a high rate of patients who smoked after transplantation (22/84 = 26%). Four patients confessed smoking after undergoing the blood test. Non-smokers were defined as denying it in the questionnaire and having CO-Mb levels < 2.5% in repeated measurements.All but one were smokers before heart transplantation. Mean consumption was11 cigarettes per day. Five and 10 years survival was significantly reducedin smokers vs. non-smokers (37 vs. 80% and 10 vs. 74%, respectively, P <0.0001). Survival curves diverged dramatically after 4 years of observation. Smokers had a higher prevalence of transplant vasculopathy as revealed by coronary angiography and/or autopsy (10/22 smokers vs. 2/62non-smokers, P < 0.00001) and a higher rate of malignancies (7/22 smokers developed cancer, as compared to 4 cancers in 62 non-smokers, P =0.0001). The primary site of cancer was the lung in 5/6 smoking andlymphoma in all non-smoking cancer patients. CONCLUSIONS: Our data show that the prevalence of smoking after heart transplantation may berelatively high, especially in former smokers. Repeated measurements ofCO-Hb could be helpful in its detection. Despite a relatively low cigarette count, smoking is a major risk factor of morbidity and mortality after heart transplantation (HTx). Approximately 4 years of exposure time is needed to uncover its negative influence. These findings should lead toa ggressive smoking screening and weaning programs in every HTx center.</description><identifier>ISSN: 1010-7940</identifier><identifier>EISSN: 1873-734X</identifier><identifier>DOI: 10.1016/S1010-7940(97)00156-5</identifier><identifier>PMID: 9262083</identifier><identifier>CODEN: EJCSE7</identifier><language>eng</language><publisher>Amsterdam: Elsevier Science B.V</publisher><subject>Biological and medical sciences ; Carboxyhemoglobin - analysis ; Female ; Heart Transplantation - mortality ; Humans ; Male ; Medical sciences ; Middle Aged ; Multivariate Analysis ; Postoperative Period ; Risk Factors ; Smoking ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the heart ; Survival Analysis</subject><ispartof>European journal of cardio-thoracic surgery, 1997-07, Vol.12 (1), p.70-74</ispartof><rights>1997</rights><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c493t-dbc634d725dce381e96190680ba56a30e9cfcdd22e3a4bb45c5d1a7c757556193</citedby><cites>FETCH-LOGICAL-c493t-dbc634d725dce381e96190680ba56a30e9cfcdd22e3a4bb45c5d1a7c757556193</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,776,780,785,786,23909,23910,25118,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2752000$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9262083$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>NÄGELE, H</creatorcontrib><creatorcontrib>KALMAR, P</creatorcontrib><creatorcontrib>RÖDIGER, W</creatorcontrib><creatorcontrib>STUBBE, H. M</creatorcontrib><title>Smoking after heart transplantation: An underestimated hazard?</title><title>European journal of cardio-thoracic surgery</title><addtitle>Eur J Cardiothorac Surg</addtitle><addtitle>Eur J Cardiothorac Surg</addtitle><description>OBJECTIVE: Risk factors for the development of vasculopathy and malignancies as the most important causes of morbidity and mortality after heart transplantation are not well defined. METHODS: Univariate and multivariate Cox regression analysis of the data derived from our 84 survivors of more than 3 months after orthotopic heart transplantation between 1984 and 1996. Measurement of carbonmonoxide-hemoglobin blood levels with an ABL 520 analyzer. RESULTS: Recipient or donor age, the mode of immunosuppression, total-, LDL- and HDL- cholesterol, the HDL/LDL-ratio,triglycerides, hypertension, diabetes mellitus, CMV status and rejection episodes had no independent influence on total mortality or the occurrence of graft vasculopathy or cancer. By means of an intensive questionnaire (incase of deceased patients, by their relatives) and measurement of CO-Hb blood levels we detected a high rate of patients who smoked after transplantation (22/84 = 26%). Four patients confessed smoking after undergoing the blood test. Non-smokers were defined as denying it in the questionnaire and having CO-Mb levels < 2.5% in repeated measurements.All but one were smokers before heart transplantation. Mean consumption was11 cigarettes per day. Five and 10 years survival was significantly reducedin smokers vs. non-smokers (37 vs. 80% and 10 vs. 74%, respectively, P <0.0001). Survival curves diverged dramatically after 4 years of observation. Smokers had a higher prevalence of transplant vasculopathy as revealed by coronary angiography and/or autopsy (10/22 smokers vs. 2/62non-smokers, P < 0.00001) and a higher rate of malignancies (7/22 smokers developed cancer, as compared to 4 cancers in 62 non-smokers, P =0.0001). The primary site of cancer was the lung in 5/6 smoking andlymphoma in all non-smoking cancer patients. CONCLUSIONS: Our data show that the prevalence of smoking after heart transplantation may berelatively high, especially in former smokers. Repeated measurements ofCO-Hb could be helpful in its detection. Despite a relatively low cigarette count, smoking is a major risk factor of morbidity and mortality after heart transplantation (HTx). Approximately 4 years of exposure time is needed to uncover its negative influence. These findings should lead toa ggressive smoking screening and weaning programs in every HTx center.</description><subject>Biological and medical sciences</subject><subject>Carboxyhemoglobin - analysis</subject><subject>Female</subject><subject>Heart Transplantation - mortality</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Postoperative Period</subject><subject>Risk Factors</subject><subject>Smoking</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the heart</subject><subject>Survival Analysis</subject><issn>1010-7940</issn><issn>1873-734X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkF1PHCEUhompUav9CSZzYRp7gR5ggKEXGrutH9WkF2o03hAGGB13d2YLTFL99WXddZMmvQGS87y8Jw9CuwQOCBBxeJ1PwFKVsK_kFwDCBeZraItUkmHJyvsP-f2ObKKPMT4DgGBUbqANRQWFim2ho-tpP267x8I0yYfiyZuQihRMF2cT0yWT2r77Wpx0xdA5H3xM7dQk74on82qCO95B642ZRP9peW-j29MfN6NzfPXr7GJ0coVtqVjCrraClU5S7qxnFfFKEAWigtpwYRh4ZRvrHKWembKuS265I0ZaySXnGWXb6PPi31nofw95DT1to_WTvKPvh6ilogSUgAzyBWhDH2PwjZ6FvHJ40QT03Jt-86bnUrSS-s2b5jm3uywY6ql3q9RSVJ7vLecmWjNpsiHbxhVGJafZbsZggfXD7P_N-J9mPG_Gi0gbk_-zCpkw1kIyyfX5_YMeiW93lxX9qb-zv7DckeM</recordid><startdate>19970701</startdate><enddate>19970701</enddate><creator>NÄGELE, H</creator><creator>KALMAR, P</creator><creator>RÖDIGER, W</creator><creator>STUBBE, H. M</creator><general>Elsevier Science B.V</general><general>Elsevier Science</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19970701</creationdate><title>Smoking after heart transplantation: An underestimated hazard?</title><author>NÄGELE, H ; KALMAR, P ; RÖDIGER, W ; STUBBE, H. M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c493t-dbc634d725dce381e96190680ba56a30e9cfcdd22e3a4bb45c5d1a7c757556193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Biological and medical sciences</topic><topic>Carboxyhemoglobin - analysis</topic><topic>Female</topic><topic>Heart Transplantation - mortality</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Postoperative Period</topic><topic>Risk Factors</topic><topic>Smoking</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the heart</topic><topic>Survival Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>NÄGELE, H</creatorcontrib><creatorcontrib>KALMAR, P</creatorcontrib><creatorcontrib>RÖDIGER, W</creatorcontrib><creatorcontrib>STUBBE, H. M</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of cardio-thoracic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>NÄGELE, H</au><au>KALMAR, P</au><au>RÖDIGER, W</au><au>STUBBE, H. M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Smoking after heart transplantation: An underestimated hazard?</atitle><jtitle>European journal of cardio-thoracic surgery</jtitle><stitle>Eur J Cardiothorac Surg</stitle><addtitle>Eur J Cardiothorac Surg</addtitle><date>1997-07-01</date><risdate>1997</risdate><volume>12</volume><issue>1</issue><spage>70</spage><epage>74</epage><pages>70-74</pages><issn>1010-7940</issn><eissn>1873-734X</eissn><coden>EJCSE7</coden><abstract>OBJECTIVE: Risk factors for the development of vasculopathy and malignancies as the most important causes of morbidity and mortality after heart transplantation are not well defined. METHODS: Univariate and multivariate Cox regression analysis of the data derived from our 84 survivors of more than 3 months after orthotopic heart transplantation between 1984 and 1996. Measurement of carbonmonoxide-hemoglobin blood levels with an ABL 520 analyzer. RESULTS: Recipient or donor age, the mode of immunosuppression, total-, LDL- and HDL- cholesterol, the HDL/LDL-ratio,triglycerides, hypertension, diabetes mellitus, CMV status and rejection episodes had no independent influence on total mortality or the occurrence of graft vasculopathy or cancer. By means of an intensive questionnaire (incase of deceased patients, by their relatives) and measurement of CO-Hb blood levels we detected a high rate of patients who smoked after transplantation (22/84 = 26%). Four patients confessed smoking after undergoing the blood test. Non-smokers were defined as denying it in the questionnaire and having CO-Mb levels < 2.5% in repeated measurements.All but one were smokers before heart transplantation. Mean consumption was11 cigarettes per day. Five and 10 years survival was significantly reducedin smokers vs. non-smokers (37 vs. 80% and 10 vs. 74%, respectively, P <0.0001). Survival curves diverged dramatically after 4 years of observation. Smokers had a higher prevalence of transplant vasculopathy as revealed by coronary angiography and/or autopsy (10/22 smokers vs. 2/62non-smokers, P < 0.00001) and a higher rate of malignancies (7/22 smokers developed cancer, as compared to 4 cancers in 62 non-smokers, P =0.0001). The primary site of cancer was the lung in 5/6 smoking andlymphoma in all non-smoking cancer patients. CONCLUSIONS: Our data show that the prevalence of smoking after heart transplantation may berelatively high, especially in former smokers. Repeated measurements ofCO-Hb could be helpful in its detection. Despite a relatively low cigarette count, smoking is a major risk factor of morbidity and mortality after heart transplantation (HTx). Approximately 4 years of exposure time is needed to uncover its negative influence. These findings should lead toa ggressive smoking screening and weaning programs in every HTx center.</abstract><cop>Amsterdam</cop><pub>Elsevier Science B.V</pub><pmid>9262083</pmid><doi>10.1016/S1010-7940(97)00156-5</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1010-7940 |
ispartof | European journal of cardio-thoracic surgery, 1997-07, Vol.12 (1), p.70-74 |
issn | 1010-7940 1873-734X |
language | eng |
recordid | cdi_proquest_miscellaneous_79210960 |
source | Oxford University Press Journals All Titles (1996-Current); MEDLINE; EZB-FREE-00999 freely available EZB journals |
subjects | Biological and medical sciences Carboxyhemoglobin - analysis Female Heart Transplantation - mortality Humans Male Medical sciences Middle Aged Multivariate Analysis Postoperative Period Risk Factors Smoking Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the heart Survival Analysis |
title | Smoking after heart transplantation: An underestimated hazard? |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T09%3A29%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Smoking%20after%20heart%20transplantation:%20An%20underestimated%20hazard?&rft.jtitle=European%20journal%20of%20cardio-thoracic%20surgery&rft.au=N%C3%84GELE,%20H&rft.date=1997-07-01&rft.volume=12&rft.issue=1&rft.spage=70&rft.epage=74&rft.pages=70-74&rft.issn=1010-7940&rft.eissn=1873-734X&rft.coden=EJCSE7&rft_id=info:doi/10.1016/S1010-7940(97)00156-5&rft_dat=%3Cproquest_cross%3E79210960%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79210960&rft_id=info:pmid/9262083&rft_oup_id=10.1016/S1010-7940(97)00156-5&rfr_iscdi=true |